Development and external validation of a contrastive learning foundation model for ECG-based prediction of cardiovascular diseases and outcomes

Lancet Digit Health. 2026 Sep 1:101092. doi: 10.1016/j.landig.2026.101092. Online ahead of print.ABSTRACTBACKGROUND: Automated electrocardiogram (ECG) assessment tools to assist clinicians in diagnosis have improved substantially over the past decade; however, the full diagnostic and predictive pote

M Michael Ko

Clinical impact of Moraxella catarrhalis detection in respiratory illnesses: a comparative study of pediatric and adult populations in Taiwan

J Microbiol Immunol Infect. 2026 Aug 27:S1684-1182(26)00104-0. doi: 10.1016/j.jmii.2026.08.006. Online ahead of print.ABSTRACTBACKGROUND: Moraxella catarrhalis is a prevalent respiratory pathogen in children and adults. While its roles in acute otitis media and chronic obstructive pulmonary disease

Y Yen-Chieh Chin

Essential antiarrhythmic drug accessibility worldwide: A multi-survey study and comprehensive evaluation of access and supply challenges

Europace. 2026 Sep 2:euag220. doi: 10.1093/europace/euag220. Online ahead of print.ABSTRACTBACKGROUND AND AIMS: Antiarrhythmic drugs (AADs) are essential for preventing symptoms, morbidity, and mortality associated with cardiac arrhythmias. However, concerns are increasing about their accessibility.

P Pieter G Postema

High Prevalence of the JAK2V617F Mutation in Patients With Acute Coronary Syndrome

Eur J Haematol. 2026 Sep 1. doi: 10.1111/ejh.70311. Online ahead of print.ABSTRACTBACKGROUND: The JAK2V617F mutation is a driver mutation in Philadelphia-negative chronic myeloproliferative neoplasms (MPNs), including polycythemia vera, essential thrombocythemia, and myelofibrosis. Recent studies ha

B Balla Evelin

Hyperbaric Oxygen Therapy for Diabetic Foot Ulcers in Sub-Saharan Africa: A Critical Review of Clinical Evidence, Health-System Feasibility and Public Health Implications

Int Wound J. 2026 Sep;23(9):e71027. doi: 10.1111/iwj.71027.ABSTRACTDiabetic foot ulcers are an important cause of morbidity, amputation, disability and healthcare expenditure in sub-Saharan Africa, where limitations in preventive foot care, referral pathways, vascular services, multidisciplinary wou

M Matthew Chibunna Igwe

Implementation and evaluation of a quality improvement initiative for central venous catheter management in neonates undergoing therapeutic hypothermia for perinatal asphyxia

BMJ Paediatr Open. 2026 Sep 1;10(1):e004817. doi: 10.1136/bmjpo-2026-004817.ABSTRACTOBJECTIVES: Therapeutic hypothermia (TH) is an effective treatment for hypoxic-ischaemic encephalopathy in infants following perinatal asphyxia, reducing mortality and morbidity when initiated within 6 hours after bi

M Margreet R Koolen-De Koninck

Divergent Obesity Classification Between the Edmonton Obesity Staging System and the Lancet Commission Model

Obesity (Silver Spring). 2026 Sep 1. doi: 10.1002/oby.70295. Online ahead of print.ABSTRACTOBJECTIVE: BMI alone does not capture obesity-related health heterogeneity. The Edmonton Obesity Staging System (EOSS) grades obesity severity based on comorbidities and functional impairment, whereas the Lanc

T Tobias Hagemann

Pulmonary arteriovenous malformation (PAVM) with hereditary haemorrhagic telangiectasia (HHT): a rare cause of paradoxical embolic stroke

BMJ Case Rep. 2026 Sep 1;19(9):e274226. doi: 10.1136/bcr-2026-274226.ABSTRACTPulmonary arteriovenous malformation (PAVM), a manifestation of hereditary haemorrhagic telangiectasia (HHT), is rarely encountered but a significant cause of seemingly cryptogenic strokes. In cases of PAVM, there is an abn

S Sofia Frangiamore

Intraventricular haemorrhage (IVH) and associated clinical characteristics in outborn preterm infants <32 weeks undergoing neonatal transport in Western Australia: a retrospective cohort study (2011-2021)

BMJ Open. 2026 Sep 1;16(9):e120592. doi: 10.1136/bmjopen-2026-120592.ABSTRACTOBJECTIVES: To evaluate maternal, infant and transport factors associated with intraventricular haemorrhage (IVH) in outborn preterm infants <32 weeks' gestation in Western Australia.DESIGN: Retrospective cohort study.SETTI

S Saumil Desai

Management of Upper Extremity Vascular Anomalies

Clin Plast Surg. 2026 Oct;53(4):619-627. doi: 10.1016/j.cps.2026.05.012. Epub 2026 Jul 1.ABSTRACTVascular anomalies are classified as malformations or tumors. Depending on the vascular anomaly's location, extent, genetics, and effect on the patient, symptoms may be managed surgically, medically, usi

N Nada Rizk

Management of Combined Vascular Malformations

Clin Plast Surg. 2026 Oct;53(4):605-618. doi: 10.1016/j.cps.2026.05.011. Epub 2026 Jul 6.ABSTRACTCombined vascular malformations are complex, heterogeneous lesions increasingly classified by anatomic components and genetic drivers, specifically the PI3K/AKT/mTOR pathway (PROS) and RASA1 mutations. T

A Ann M Kulungowski

Management of Arteriovenous Malformations

Clin Plast Surg. 2026 Oct;53(4):593-604. doi: 10.1016/j.cps.2026.05.010. Epub 2026 Jul 3.ABSTRACTArteriovenous malformations (AVMs)-lesions comprising abnormal communications between arteries and veins with no intervening capillary bed-are among the most challenging vascular anomalies to treat. Surg

A Adam Gascoigne

Management of Venous Malformations

Clin Plast Surg. 2026 Oct;53(4):577-592. doi: 10.1016/j.cps.2026.05.009. Epub 2026 Jul 6.ABSTRACTVenous malformations (VMs) are slow-flow vascular anomalies arising from hyperactivation of the TIE2-PI3K-AKT-mTOR pathway. This comprehensive review delineates the diverse clinical landscape of VMs, ran

J Julien Coulie

Management of Capillary Malformations

Clin Plast Surg. 2026 Oct;53(4):555-563. doi: 10.1016/j.cps.2026.05.007.ABSTRACTCapillary malformation (CM), or port wine birthmark, is a congenital low-flow vascular malformation of dilated capillaries and postcapillary venules. It often affects the face and may darken, thicken, or develop nodules

P Pierre-Olivier Grenier

Surgical Management of Vascular Anomalies

Clin Plast Surg. 2026 Oct;53(4):537-540. doi: 10.1016/j.cps.2026.05.005. Epub 2026 Jul 14.ABSTRACTSurgical management of vascular anomalies depends on the type of lesion, location, symptoms, and consideration of other treatment options. A correct diagnosis must be confirmed before choosing managemen

A Arin K Greene

Medical Management of Vascular Anomalies

Clin Plast Surg. 2026 Oct;53(4):529-535. doi: 10.1016/j.cps.2026.05.004. Epub 2026 Jul 8.ABSTRACTMost vascular anomalies are caused by mutations in the PI3K-AKT-mTOR or RAS-RAF-MEK-ERK signaling pathways. This knowledge, along with increasing availability of genetic testing for molecular diagnosis,

T Tishi Shah

Laser Management of Vascular Anomalies

Clin Plast Surg. 2026 Oct;53(4):517-527. doi: 10.1016/j.cps.2026.05.002. Epub 2026 Jun 30.ABSTRACTThis article reviews the evolving role of laser therapy in the management of vascular anomalies, emphasizing advances in selective photothermolysis, wavelength optimization, pulse modulation, and epider

S Shih-Jen Chang

Interventional Radiology Management of Vascular Anomalies

Clin Plast Surg. 2026 Oct;53(4):503-515. doi: 10.1016/j.cps.2026.05.001. Epub 2026 Jun 30.ABSTRACTVascular anomalies span a wide biological spectrum, from self-involuting infantile hemangiomas to life-threatening arteriovenous malformations. This review focuses on the conditions most commonly manage

G Gulraiz Chaudry

Classification and Diagnosis of Vascular Anomalies

Clin Plast Surg. 2026 Oct;53(4):497-501. doi: 10.1016/j.cps.2026.05.003. Epub 2026 Jul 13.ABSTRACTVascular anomalies are disorders of the endothelium affecting approximately 5% of the population. Lesions are divided into tumors and malformations. The most common tumors are infantile hemangioma, cong

A Arin K Greene

Early-life exposure to flusilazole causes transgenerational cardiac developmental defects in zebrafish and its potential causes

J Environ Sci (China). 2026 Oct;168:392-399. doi: 10.1016/j.jes.2026.01.060. Epub 2026 Jan 27.ABSTRACTWith the growing use of novel triazole fungicides, concerns over their toxicity and ecological effects have intensified. This study investigated the transgenerational cardiac toxicity of flusilazole

Y Yue Wang

Letter to the Editor regarding: "Attainment of Low-Density Lipoprotein Cholesterol Goals and Statin Use in Patients With Atherosclerotic Cardiovascular Disease in Australian General Practice: Are We Doing Enough?"

No abstractHeart Lung Circ. 2026 Sep;35(9):e128. doi: 10.1016/j.hlc.2026.01.012.NO ABSTRACTPMID:42680365 | DOI:10.1016/j.hlc.2026.01.012

S Simon B Dimmitt

GABA-enriched Lactobacillus buchneri XBMU-C1 fermentation broth lowers blood pressure in L-NAME-induced hypertensive rats via RAAS suppression and PI3K/Akt/eNOS activation

Food Res Int. 2026 Oct 31;242(Pt 3):120054. doi: 10.1016/j.foodres.2026.120054. Epub 2026 Jul 18.ABSTRACTγ-Aminobutyric acid (GABA)-producing lactic acid bacteria are promising natural alternatives for hypertension management. Here, we isolated a novel high GABA-yielding strain, Lactobacillus buchne

D Dandan Gao

Effect of a 6-month low-carbohydrate diet on the circulating fatty acid composition in patients with type 2 diabetes: a secondary analysis of an open-label randomized controlled trial

Am J Clin Nutr. 2026 Sep;124(3):101400. doi: 10.1016/j.ajcnut.2026.101400. Epub 2026 Aug 14.ABSTRACTBACKGROUND: Circulating fatty acid profiles are linked to cardiovascular disease risk and mortality. Short-term interventions suggest that low-carbohydrate diets (LCDs) promote cardioprotective shifts

J Julie Lind Pilegaard Rasmussen

Cardiovascular disease and amyloidosis in phase III multiple myeloma trials: a systematic review of eligibility, screening and event reporting

Open Heart. 2026 Sep 1;13(2):e004240. doi: 10.1136/openhrt-2026-004240.ABSTRACTBACKGROUND: Cardiovascular disease (CVD) and light chain (AL) amyloidosis are important causes of morbidity and mortality in patients with multiple myeloma (MM). Additionally, MM therapies can have cardiovascular effects.

O Oliver Henriques Peck